SEC 13F Intelligence

Ghost Tree Capital, LLC / XENE

Ghost Tree Capital, LLC’s Xenon Pharmaceuticals Inc Position

Does Ghost Tree Capital, LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 99.0K shares worth $3M in Q3 2023; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$3M
Q3 2023
Shares
99.0K
% of Portfolio
+1.11%
Quarters Held
12
position exited

Position History XENE

Reported value by quarter
Q1 ’20: $4MQ1 ’20Q2 ’20: $4MQ3 ’20: $4MQ3 ’20Q4 ’20: $11MQ1 ’21: $15MQ1 ’21Q2 ’21: $16MQ3 ’21: $12MQ3 ’21Q4 ’21: $3MQ1 ’22: $3MQ1 ’22Q1 ’23: $7MQ2 ’23: $7MQ2 ’23Q3 ’23: $3Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202399.0K$3M+1.11%
Q2 2023185.0K$7M+2.35%
Q1 2023200.0K$7M+2.12%
Q1 2022100.0K$3M+0.66%
Q4 2021100.0K$3M+1.12%
Q3 2021790.0K$12M+3.53%
Q2 2021850.0K$16M+4.35%
Q1 2021850.0K$15M+3.58%
Q4 2020700.0K$11M+2.40%
Q3 2020325.0K$4M+1.04%
Q2 2020325.0K$4M+1.08%
Q1 2020325.0K$4M+0.98%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of XENE.